Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wheat germ peptide refers to the mixture of bioactive peptides derived from wheat germ proteins, typically obtained through enzymatic hydrolysis. These peptides exhibit diverse biological functions including antioxidant, anti-inflammatory, lipid-lowering, immune-modulatory, anti-fatigue, antibacterial, and anticancer activities. Notable mechanisms include modulation of inflammatory markers, regulation of immune function, protection against oxidative stress, and interactions with cholesterol and glucose metabolism. Wheat germ peptides are considered promising functional ingredients and dietary supplements, potentially beneficial for conditions such as hyperlipidemia, diabetes, inflammation, cancer, and gut health. While preclinical data are robust, clinical evidence is still emerging, and larger human trials are needed to confirm efficacy and safety[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wheat germ peptide.